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Non‑linear association 
of anthropometric measurements 
and pulmonary function
Rui‑Heng Zhang1,5, Jian‑Bo Zhou2,5*, Yao‑Hua Cai1, Lin‑Ping Shu1, Jinkui Yang2, 
Wenbin Wei3 & Albert Lecube4
This study examined the association of anthropometric measurements [body mass index (BMI), waist 
circumference (WC), percentage body fat (PBF), body roundness index (BRI) and A Body Shape Index 
(ABSI)] with pulmonary function using a United States national cohort. This cross‑sectional study 
included 7346 participants. The association between anthropometric measurements and pulmonary 
function was assessed by multivariable linear regression. Where there was evidence of non‑linearity, 
we applied a restricted cubic spline to explore the non‑linear association. All analyses were weighted 
to represent the U.S. population and to account for the intricate survey design. After adjusting for 
age, race, education, smoking, and physical activity, both underweight and obesity were associated 
with reduced forced expiratory volume in 1 s  (FEV1) and forced vital capacity (FVC). Furthermore, the 
associations between BMI and  FEV1, as well as FVC, were reversed U‑shape in both males and females. 
Similar non‑linear association shape occurred in WC, PBF, BRI and ABSI. Conclusion: BMI, WC, PBF, 
BRI, ABSI are non‑linearly associated with pulmonary function. Reduced pulmonary function is a risk 
factor for future all‑cause mortality and cardiovascular events; thus, this nonlinearity may explain the 
U‑shape or J‑shape association of BMI with overall mortality and cardiovascular events.
Over the past ~ 50 years, the prevalence of obesity has increased worldwide, ranging from 3.7% in Japan to 38.2% 
in the United States when using body mass index ≥ 30 kg/m2 as cut-off  value1. In addition, obesity has become 
a major public health concern, with enormous physical, social, economic, and psychological  consequences2,3. 
For example, obesity increases the risk of many serious diseases and health conditions, such as type 2 diabetes, 
cardiovascular diseases, obstructive sleep apnea, non-alcoholic fatty liver disease, and  cancer4,5. Furthermore, 
cross-sectional studies have also reported a reduction in forced expiratory volume in 1 s  (FEV1) and forced vital 
capacity (FVC) in obese participants, suggesting that excess body weight has deleterious effects on pulmonary 
function either directly or  indirectly6–9.
However, results showing the negative impact of excess body weight are based mainly on the unverified 
assumption that the excess body weight is negatively and linearly associated with pulmonary function. For 
example, in a large cross-sectional study of the Korean population, being underweight was also associated 
with an impaired pulmonary  function10. This data suggests a complex association between lung function and 
anthropometric measures. Additionally, whether abdominal obesity or total body fat has a disparate association 
with lung function compared to traditional anthropometric measure (BMI) has not been previously assessed 
in large populations.
Therefore, this study sought to examine in detail the association between anthropometric measures [body 
mass index (BMI), waist circumference (WC), percentage body fat (PBF), body roundness index (BRI), and A 
body shape index (ABSI)] and pulmonary function using data from the 2007–2012 National Health and Nutri-
tion Examination Survey (NHANES), a U.S. national cohort.
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Results
Cross‑sectional characteristics of the participants. The primary clinical and pulmonary data of the 
7346 participants (Fig. 1) that were included in this cross-sectional study according to their BMI classification 
(Table 1). The weighted proportions of underweight, normal weight, overweight, and obesity were 1.5%, 32.0%, 
35.4%, and 31.0%, respectively. Compared to participants with normal weight, those with obesity were signifi-
cantly older and more likely to be male, Mexican American, and non-Hispanic Black, with lower educational 
level, physically inactive, and non-smokers. We first examined the correlation among anthropometric meas-
urements (Supplementary Table 1 and Supplementary Fig. 1). All anthropometric measurements were closely 
correlated with each other (R-squared value ranged from 0.761 to 0.917), except for ABSI. ABSI showed good 
allometric characteristics with other measurements. Both underweight and obesity groups exhibited signifi-
cantly reduced  FEV1 and FVC measurements in comparison to normal-weight participants, without significant 
differences between participants with normal weight and overweight. The association remained significant after 
adjusting for age, race, educational level, physical activity (MET score), and smoking status in both males and 
females (Table  2). Additionally, obesity was associated with a slightly elevated  FEV1/FVC ratio, indicating a 
restrictive pulmonary dysfunction pattern.
The association between obesity and pulmonary function no longer existed after additional adjustment for 
insulin resistance or C-reactive protein (CRP, Supplementary Table 2). We then determined the relationship 
between obesity (BMI ≥ 30) and pulmonary function, after stratifying by insulin resistance or CRP. Obesity was 
associated with lower  FEV1, FVC, and higher  FEV1/FVC ratio only in the highest insulin resistance/CRP tertile 
(Supplementary Table 3). We performed a sensitivity analysis by including only non-smokers. The sensitivity 
analysis excluded the possibility of residual confounding by smoking (Supplementary Table 4).
Reversed U‑shape association between BMI, WC, PBF, BRI, ABSI and pulmonary func‑
tion. After adjusting for age, race, education, smoking, and physical activity, associations between BMI, WC, 
PBF, BRI, ABSI and  FEV1, as well as FVC were reverse U-shaped in both sexes (Figs. 2 and 3). The  FEV1 and 
FVC reached a peak at BMIs in the overweight range, with positive associations below and inverse associations 
Figure 1.  Flow gram of included participants. PFTs pulmonary function tests, ATS American Thoracic Society.
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above the range. In this way, the decrease of  FEV1 and FVC after BMI change point seemed to be more profound 
in males than in females. Additionally, BMI was positively associated with  FEV1/FVC ratio, where nonlinearity 
only existed in the female participants. The similar shape of non-linear associations was also found when the 
relation between WC, PBF, BRI, ABSI and lung function values was evaluated. This non-linear associations still 
existed after transforming these anthropometric measurements into age and sex standardized Z-score (Supple-
mentary Fig. 2).
We further validated the precise non-linear association and excluded the possibility of artificial nonlinearity. 
As exhibited in Table 3, Figs. 2 and 3, The non-linearity change points for pulmonary function were approxi-
mately within the second tertile of anthropometric measures. Thus, a segmented, multivariable linear regression 
was performed. The results validated the reversed U-shaped association between BMI and  FEV1 and FVC in both 
female and male participants. Furthermore, these reversed U-shaped association was more profound in male 
participants with obesity, where the regression coefficient was almost twice as high as that in females (− 0.35 
vs. − 0.19 for  FEV1, − 0.42 vs. − 0.26 for FVC).
Table 1.  Cross-sectional characteristics of participants. Data were weighted estimates and expressed as mean 
(standard error) or median [percentile 25–percentile 75] (n = number of participants in analysis). Education 
level, percentage of participants, completed college graduate or above. HOMA-IR homeostasis model of 
assessment for insulin resistance index, MET score metabolic equivalent scores per week. *p < 0.05 compared to 
normal weight.
Underweight (n = 108) Normal weight (n = 2198) Overweight (n = 2557) Obesity (n = 2483)
Weighted proportion, %(n = 7346) 1.5 (0.2) 32.0 (1.0) 35.4 (0.9) 31.0 (0.8)
Age (years) (n = 7346) 36.9 (1.8)* 40.4 (0.7) 44.9 (0.5)* 44.0 (0.5) *
Male %(n = 7346) 21.5 (4.6)* 43.2 (1.3) 57.5 (1.2)* 49.0 (1.3) *
Ethnicity % (n = 7346)
Mexican American 4.2 (1.8) 7.0 (0.9) 11.2 (1.5) * 11.4 (1.6) *
Non-Hispanic White 85.1 (2.8) 83.7 (1.4) 79.6 (1.9) * 73.8 (2.6) *
Non-Hispanic Black 10.8 (1.9) 9.3 (1.0) 9.2 (1.0) 14.8 (1.8) *
Education level (%)(n = 7331) 26.7 (5.5) 34.6 (1.9) 32.3 (1.9) 24.9 (1.5) *
Current smoker % (n = 7346) 28.0 (5.2) 21.5 (1.6) 16.7 (1.2) * 13.8 (0.9) *
MET scores/week (n = 7346) 480 [120–1080] 600 [180–1320] 540 [160–1440] 400 [80–1320]
HOMA-IR (n = 3038) 0.9 [0.6–1.2]* 1.4 [1.0–2.0] 2.3 [1.6–3.4] * 3.6 [2.5–5.3] *
C-reactive protein (mg/dL) 
(n = 5165) 0.03 [0.01–0.07] * 0.07 [0.03–0.18] 0.15 [0.07–0.30] * 0.31 [0.15–0.66] *
BMI (kg/m2) (n = 7346) 17.75 (0.07) * 22.42 (0.06) 27.36 (0.04) * 35.26 (0.16) *
Height (cm) (n = 7346) 166.8 (0.7) * 169.8 (0.2) 170.7 (0.3) * 169.7 (0.3)
Waist circumference (cm) 
(n = 7206) 70.9 (0.5) * 82.5 (0.3) 95.8 (0.2) * 112.6 (0.4) *
Percentage body fat (%) (n = 4598) 24.3 (0.5) * 29.2 (0.2) 33.2 (0.2) * 39.0 (0.3) *
Body roundness index (n = 7038) 2.09 (0.05) * 3.13 (0.03) 4.62 (0.02) * 7.06 (0.05) *
A body shape index (n = 7206) 0.0808 (0.0006) * 0.0797 (0.0002) 0.0808 (0.0001) * 0.0807 (0.0001) *
FEV1 (%predicted) (n = 7346) 90.8 (1.8) * 98.0 (0.5) 98.6 (0.3) 96.5 (0.4) *
FVC (%predicted) (n = 7346) 92.9 (1.4) * 101.7 (0.4) 101.5 (0.3) 98.3 (0.4) *
FEV1/FVC ratio (n = 7346) 80.6 (1.1) * 79.5 (0.4) 77.8 (0.2) * 79.0 (0.2)
Table 2.  Association of body weight and pulmonary function. Data were weighted estimates and expressed as 
mean [95% confidence interval]. Multiple linear regression was adjusted for age, race, education level, physical 
activity (MET score), smoking status. Bold: p < 0.05.
Underweight (n = 108) Normal weight (n = 2198) Overweight (n = 2557) Obesity (n = 2483)
Female
FEV1 %predicted − 6.58 [−10.95, −2.21] Reference 0.30 [−0.86, 1.47] −1.35 [−2.65, −0.06]
FVC %predicted −8.48 [−11.90, −5.06] Reference −0.03 [−1.16, 1.09] −2.92 [−4.14, −1.70]
FEV1/FVC ratio % 1.08 [−0.62, 2.77] Reference 0.15 [−0.46, 0.75] 1.03 [0.41, 1.65]
Male
FEV1 %predicted −9.43 [−14.28, −4.57] Reference 1.16 [−0.29, 2.62] −1.58 [−2.92, −0.23]
FVC %predicted −9.82 [−14.86, −4.77] Reference 0.05 [−1.29, 1.38] −3.23 [−4.57, −1.89]
FEV1/FVC ratio % 0.52 [−3.58, 4.62] Reference 0.84 [−0.01, 1.68] 1.19 [0.45, 1.92]
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Figure 2.  Reverse U-shaped association between BMI, WC, PBF, BRI, ABSI and pulmonary function in female. 
Data were weighted estimates. The shadow area represents a 95% confidence interval.  Pinon-linear was estimated by 
a two-line piecewise linear model. The model was adjusted for age, race, education, smoking, physical activity.
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Figure 3.  Reverse U-shaped association between BMI, WC, PBF, BRI, ABSI and pulmonary function in male. 
Data were weighted estimates. The shadow area represents a 95% confidence interval.  Pinon-linear was estimated by 
a two-line piecewise linear model. The model was adjusted for age, race, education, smoking, physical activity.
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Discussion
In this study, we demonstrated the non-linear association between anthropometric measures (BMI, WC, PBF, 
BRI and ABSI) and pulmonary function. First, we confirmed in a national cohort that both underweight and 
obesity classifications according to BMI, were associated with reduced  FEV1 and FVC. Moreover, after adjust-
ing for age, sex, race, education, smoking, and physical activity, associations between BMI and  FEV1, as well as 
between BMI and FVC were reversed U-shaped. Finally, similar non-linear association shape was observed in 
WC, PBF, BRI and ABSI.
This nonlinear association has been indicated by a well-performed meta-analysis11, in which both normal 
weight and overweight had similar pulmonary functions regarding  FEV1 and FVC. A simple linear model can-
not well-explain this phenomenon. In our study, using restricted cubic spline, we initially demonstrated the 
Table 3.  Association between BMI, WC, PBF, BRI,ABSI and pulmonary function. Data were weighted 
estimates and expressed as mean [95% confidence interval]. Multiple linear regression was adjusted for age, 
race, education level, physical activity (MET score), smoking status. For example, for female participants with 
BMI < 25.0 kg/m2, BMI was associated increased  FEV1 %predicted value after adjusting for confounder above 
(coefficient = 0.80, 95% CI 0.36–1.24, P < 0.05). Bold: p < 0.05.
Female
BMI  < 25.0 25.0–29.9 ≥ 30
FEV1 %predicted 0.80 [0.36, 1.24] −0.47 [−1.15, 0.20] −0.19 [−0.39, 0.00]
FVC %predicted 1.02 [0.62, 1.43] −0.61 [−1.23, 0.02] −0.26 [−0.44, −0.09]
FEV1/FVC ratio % −0.14 [−0.35, 0.07] 0.08 [−0.29, 0.45] 0.05 [−0.02, 0.13]
Waist circumference (cm) Tertile 1 [< 86.6] Tertile 2 [86.6–100.1] Tertile 3 [> 100.1]
FEV1 %predicted 0.02 [−0.12, 0.16] −0.17 [−0.35, 0.01] −0.13 [−0.22, −0.04]
FVC %predicted 0.09 [−0.06, 0.23] −0.24 [−0.45, −0.04] −0.17 [−0.24, −0.10]
FEV1/FVC ratio % −0.07 [–0.15, 0.00] 0.05 [−0.05, 0.15] 0.02 [−0.02, 0.06]
Percentage body fat % Tertile 1 [< 37.2] Tertile 2 [37.2–42.3] Tertile 3 [> 42.3]
FEV1 %predicted 0.06 [–0.27, 0.39] 0.26 [−0.31, 0.84] −0.31 [−0.82, 0.21]
FVC %predicted 0.22 [−0.06, 0.49] −0.06 [–0.70, 0.56] −0.66 [−1.16, −0.15]
FEV1/FVC ratio % −0.12 [−0.27, 0.02] 0.27 [−0.06, 0.59] 0.26 [0.05, 0.47]
Body roundness index Tertile 1 [< 4.04] Tertile 2 [4.04–5.93] Tertile 3 [> 5.93]
FEV1 %predicted 1.02 [−0.27, 2.30] −1.14 [−2.53, 0.24] −0.58 [−1.16, 0.01]
FVC %predicted 1.71 [0.42, 3.01] −1.17 [−2.77, 0.43] −0.89 [−1.36, −0.42]
FEV1/FVC ratio % −0.51 [−1.02, 0.01] 0.02 [−0.94, 0.98] 0.22 [−0.03, 0.46]
A body shape index (per 0.001 increment) Tertile 1 [< 0.0780] Tertile 2 [0.0780–0.0819] Tertile 3 [> 0.0819]
FEV1 %predicted −0.50 [−0.81, −0.20] −0.14 [−1.04, 0.76] −0.61 [−1.11, −0.11]
FVC %predicted −0.58 [−0.88, −0.28] −0.37 [−1.24, 0.50] −0.44 [−0.75, −0.12]
FEV1/FVC ratio % 0.02 [−0.14, 0.18] 0.10 [−0.24, 0.45] −0.17 [−0.42, 0.07]
Male
BMI  < 25.0 25.0–29.9  ≥ 30
FEV1 %predicted 1.29 [0.78, 1.81] −0.68 [−1.27, −0.08] −0.35 [−0.51, −0.19]
FVC %predicted 1.38 [0.93, 1.83] −0.84 [−1.36, −0.31] −0.42 [−0.56, −0.28]
FEV1/FVC ratio % −0.08 [−0.34, 0.17] 0.09 [−0.20, 0.37] 0.05 [−0.05, 0.15]
Waist circumference (cm) Tertile 1 [< 92] Tertile 2 [92–103.9] Tertile 3 [> 103.9]
FEV1 %predicted 0.22 [0.02, 0.42] −0.09 [−0.38, 0.20] −0.17 [−0.25, −0.10]
FVC %predicted 0.32 [0.14, 0.50] −0.10 [−0.32, 0.12] −0.20 [−0.27, −0.13]
FEV1/FVC ratio % −0.10 [−0.18, −0.01] 0.01 [−0.15, 0.17] 0.01 [−0.03, 0.06]
Percentage body fat % Tertile 1 [< 25.3] Tertile 2 [25.3–29.7] Tertile 3 [> 29.7]
FEV1 %predicted 0.02 [−0.34, 0.37] −0.35 [−1.23, 0.52] −0.26 [−0.67, 0.15]
FVC %predicted 0.19 [−0.08, 0.45] −0.57 [−1.41, 0.27] −0.28 [−0.64, 0.09]
FEV1/FVC ratio % −0.15 [−0.42, 0.12] 0.14 [−0.24, 0.53] −0.02 [−0.16, 0.13]
Body roundness index Tertile 1 [< 3.82] Tertile 2 [3.82–5.25] Tertile 3 [> 5.25]
FEV1 %predicted 1.43 [−0.09, 2.95] −2.83 [−4.88, −0.77] −1.29 [−1.81, −0.78]
FVC %predicted 1.91 [0.53, 3.30] −2.61 [−4.13, −1.09] −1.41 [−1.93, −0.89]
FEV1/FVC ratio % −0.42 [−1.14, 0.30] −0.15 [−1.26, 0.96] 0.06 [−0.20, 0.33]
A body shape index (per 0.001 increment) Tertile 1 [< 0.0789] Tertile 2 [0.0789–0.0825] Tertile 3 [> 0.0825]
FEV1 %predicted −0.39 [−0.73, −0.06] −1.26 [−2.30, −0.21] −1.17 [−1.63, −0.70]
FVC %predicted −0.25 [−0.58, 0.08] −1.19 [−2.03, −0.36] −0.99 [−1.43, −0.56]
FEV1/FVC ratio % −0.12 [−0.35, 0.11] −0.01 [−0.49, 0.47] −0.17 [−0.42, 0.08]
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non-linear association between BMI and pulmonary function. BMI does not distinguish between muscle and 
body fat. In addition to BMI, we also examined the anthropometrics which measures abdominal and visceral 
adiposity, including WC, PBF, BRI and ABSI. This suggested, adiposity was associated with impaired pulmonary 
function, only after certain thresholds. ABSI, to a lesser extent, corrected nonlinearly only with  FEV1. These 
results may have potential influence on further studies. First, because the low pulmonary function is a risk factor 
for future all-cause mortality and cardiovascular  events12. It is reasonable to assume that reduced pulmonary 
function partially mediated the deleterious effect of obesity on all-cause mortality and cardiovascular events. 
Indeed, previous studies have observed that BMI and other anthropometrics had a U-shaped or J-shaped asso-
ciation with overall mortality and cardiovascular  events13–15. Second, BMI, WC, PBF, BRI, and ABSI should be 
treated as confounding factors with cautions in studies regarding pulmonary function. The unawareness of this 
nonlinear association between anthropometric measures and pulmonary function may bring potential bias.
Although the pathogenic mechanisms are not yet fully understood, plausible mechanisms may be proposed to 
explain the distinctive association between obesity and pulmonary function. The most direct mechanism involves 
the deleterious effect of adiposity on abdominal and intercostal muscle  strength16. Obesity directly alters the 
mechanical properties of the lungs and chest wall through the accumulation of fat in the mediastinum and the 
abdominal and thoracic  cavities17. This action elevates the diaphragm and also limits its downward excursion, 
causing pleural pressure to increase and functional residual capacity to  decrease18. Furthermore, obesity has been 
reported to reduce mobility, neural adaptations, and changes in muscle morphology, resulting in poorer muscle 
quality than in participants with normal  weight16.
A second potential mechanism for this pathophysiologic process involves insulin resistance, and is closely 
linked to excess body  fat18,19. In this study, we observed that obesity was associated with lower  FEV1, FVC and 
higher  FEV1/FVC ratio only in the highest insulin resistance tertile (Supplementary Table 3). Previous cross-
sectional data of 922 nondiabetic participants in the Normative Aging Study also found that fasting insulin and 
insulin resistance were negatively correlated with FVC and  FEV120. A similar result was also found in the Strong 
Heart Study among adult American  Indians21. Furthermore, the association of insulin resistance and pulmonary 
function was more profound with FVC  values22. In the British Women’s Heart and Health Study, for example, 
insulin resistance increased by 5% for a one standard deviation decrease in FVC, and 3% for  FEV1, resulting 
in an elevated  FEV1/FVC  ratio23. Thus, insulin resistance may act as a key mediator in the association between 
obesity and pulmonary function.
Another potential mechanism for this pathophysiologic process involves low-grade chronic inflammation. 
Chronic inflammation has been found with obesity in the absence of overt  infection24. Our study also revealed 
that participants with obesity had a significantly higher level of C-reactive protein. Moreover, like insulin resist-
ance, obesity was associated with lower  FEV1, FVC and higher  FEV1/FVC ratio only in the highest CRP tertile. 
In cross-sectional studies, strong inverse associations were found between CRP levels and quartiles of  FEV1 
among 1,131 healthy  participants25 and a population with metabolic syndrome and  diabetes26. Similarly, data 
from the British Regional Heart Study demonstrated significant inverse associations of baseline FVC and  FEV1 
with blood markers of inflammation, including  CRP27. Thus, low-grade chronic inflammation may also act as a 
key mediator in the association between obesity and pulmonary function.
However, this evidence cannot explain the observation that underweight participants had an even greater 
decreased pulmonary function than the participants with obesity (Table 2). In addition to the NHANES 
2007–2012 population, this phenomenon has been observed in Korea National Health and Nutrition Exami-
nation Survey  participants10, and in participants of the European Community Respiratory Health Survey and 
Swiss Cohort Study on Air Pollution and Lung and Heart Diseases in  Adults28,29. Underweight participants 
have a significantly higher rate of restrictive pulmonary dysfunction, defined as  FEV1/FVC ratio ≥ lower limit 
of normal (LLN) and FVC <  LLN28. Therefore, different mechanisms may be involved in both extremes of BMI. 
Indeed, BMI does not distinguish between muscle and body fat, while other measurements reflect less muscle 
component. This can explain the finding that a positive association between BMI and pulmonary function under 
its change points, rather than among other anthropometric measurements. (Supplementary Fig. 2). Smoking 
is more prevalent among underweight  participants29. We thus performed a sensitivity analysis, which excluded 
the possibility of residual confounding by smoking. In contrast to insulin resistance and inflammation in those 
with obesity, low muscle mass in underweight participants is one of the possible reasons for the impaired lung 
 function10. In our study, BRI and ABSI were closer to linear association with pulmonary function. Compared to 
BRI, ABSI is independent from BMI. As exhibited by previous study, muscle strength was negatively correlated 
with ABSI. These results suggests that those with a more central body profile tend to be weaker in muscle strength 
than others with the same  BMI30, resulting in to weaker forced expiratory volume and capacity. Because of our 
relatively small number of underweight participants, in-depth explorations are warranted in further studies.
Our study has many strengths, including the use of a national cohort, and it is the first to demonstrate a 
non-linear association of anthropometric measurements and pulmonary function. However, limitations should 
be mentioned. First, although our study mainly provided evidence that anthropometric measurements were 
negatively and non-linearly associated with pulmonary function, a causal association could not be demonstrated 
due to the cross-sectional nature. A further longitudinal study is needed to validate our results. Second, the asso-
ciation between obesity and pulmonary function no longer existed after additional adjustment for insulin resist-
ance or CRP. We further found that obesity was associated with lower  FEV1, FVC and higher  FEV1/FVC ratio 
only in the highest insulin resistance/CRP tertile, indicating that both insulin resistance and low-grade chronic 
inflammation may lie on the association pathway between obesity and pulmonary function. Third, although we 
used a two-line piecewise linear model to estimate a single change point, the choice of change point may also be 
inaccurate. However, the inaccuracy may only slightly affect the regression coefficient, but not the non-linear 
conclusions. Fourth, compared to the excluded participants, the included individuals were younger, more likely 
to be male, more educated, and more physically active. BMI, WC, PBF BRI and ABSI were significantly lower in 
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the included population (Supplementary Table 5). Thus, this selection procedure may potentially bias the results. 
Fifth, the inclusion and exclusion criteria of this study limited the generalizability of the results to the partici-
pants with diabetes and pulmonary comorbidities, adolescents, Asians, and other ethnic minorities. Moreover, 
it has been reported that variation across maneuvers within a single test is approximately 6%31, which may have 
led to unsupportable inferences about the statistical significance of observed differences. Lastly, residual, and 
unobserved confounding may potentially bias the results.
In conclusion, this cross-sectional study demonstrated that BMI, WC, PBF, BRI and ABSI are non-linearly 
associated with pulmonary function. Both underweight and obesity groups exhibited significantly reduced  FEV1 
and FVC measurements in comparison to normal-weight participants. Reduced pulmonary function is a risk 
factor for future all-cause mortality and cardiovascular events; thus, further longitudinal studies are needed to 
validate whether the nonlinearity can explain the U-shaped or J-shaped associations between BMI and the overall 
mortality and cardiovascular events.
Methods
Data source and participants. Data analyzed in this study were obtained from the 2007–2012 National 
Health and Nutrition Examination Survey (NHANES) data files because of the consistent pulmonary function 
test performed in those years. The NHANES, which is described in detail elsewhere, is a multistage probabil-
ity sample of the noninstitutionalised U.S. population and allows representative estimates of the U.S. popu-
lation. A total of 30,442 participants participated in NHANES from 2007 to 2012. We excluded participants 
who were: aged < 18 years (n = 11,823), ethnic minorities (n = 3612), without pulmonary function tests results 
(n = 3658), without pulmonary function tests that met American Thoracic Society (ATS) data collection stand-
ards (n = 1477), pregnant (n = 106), with pulmonary comorbidities, including asthma, chronic bronchitis, and 
emphysema (n = 1179), with diabetes (n = 1238), and without BMI information (n = 3). Diabetes was diagnosed 
based on self-report or the American Diabetes Association (ADA) standard (n = 1238)32. Ethnic minorities 
included races other than Mexican American, Non-Hispanic White, or Non-Hispanic Black, for they often lack 
corresponding spirometry reference values. Pulmonary comorbidities (including asthma, chronic bronchitis, 
and emphysema) were ascertained by self-report. In all, 7346 participants were included in this study. No par-
ticipants underwent chest/abdominal surgery within three months prior to the lung function assessment. Com-
parison between included and excluded adults in this study is shown in Supplementary Table 1.
Exposures and outcomes. The NHANES III Anthropometric Procedures Video (Centers for Disease 
Control and Prevention) illustrates the standard methodology for measuring body weight, height, WC, and 
skinfold thickness. The same methods were used in each of the continuous NHANES cycles. Based on the BMI, 
underweight, normal weight, overweight and obesity were diagnosed as: < 18·5 kg/m2; 18·5–24·9 kg/m2; 25·0–
29·9 kg/m2; and ≥ 30·0 kg/m2,  respectively33. The PBF was generated based on the age, race, height, weight, BMI, 
triceps skinfold thickness and subscapular skinfold thickness, waist and arm  circumference34. Specifically, we 
applied Model G equation in our  study34. This equation developed here is appropriate for use for multiple ethnic 
groups, is generalisable to the U.S. population, and provides a useful method for assessing the percent body fat. 
In addition to WC, we used BRI, a recently developed index of abdominal  obesity35. The BRI was calculated as:








We also used A Body Shape Index, an allometric transformed anthropometrics, to be another alternative 
approach to describe abdominal adiposity independent from  BMI36. The ABSI was calculated: ABSI = WC 
×  Weight–2/3 ×  Height5/6. It should be emphasised that we only generated PBF for participants in NHANES 
2007–2010, as triceps or subscapular skinfold thickness were not measured in NHANES 2011–2012.
During NHANES 2007–2012, spirometry was offered to all the participants aged 6 to 79 years, except those 
with the following: current chest pain; a physical problem with forceful expiration; use of supplemental oxygen; 
recent surgery of the eye, chest, or abdomen; recent heart attack, stroke, tuberculosis exposure, or coughing 
up of blood; and history of detached retina, collapsed lung, or aneurysm. Similar spirometers (Ohio 822/827 
dry-rolling seal volume spirometers, Ohio Medical, Gurnee, IL, USA) and protocols were used for conducting 
spirometry. Participants were asked to provide three acceptable maneuvers. For purposes of this study, we used 
pre-bronchodilator spirometry data with quality A (exceeds ATS data collection standards) or B (meets ATS 
data collection standards). The predicted values of pulmonary functions  (FEV1, FVC) were calculated accord-
ing to NHANES III  equations37. In brief, age, sex, ethnicity groups,  age2, and  height2 were used to generate the 
predictive values.
Covariables. The definitions and methods used for other baseline measurements (age, sex, ethnicity, weight, 
height, and WC) have been described in detail earlier. We defined “current smoker” as a participant who smoked 
every day. Insulin resistance was assessed by the homeostasis model of assessment for insulin resistance index 
(HOMA-IR), which was calculated as fasting plasma insulin (mU/L) × fasting plasma glucose (mmol/L)/22.538. 
Physical activity was assessed by the metabolic equivalent of task (MET) score as follows: vigorous work-related 
activity × 8 + Moderate work-related activity × 4 + Walking or bicycling for transportation × 4 + Vigorous leisure-
time physical activity × 8 + Moderate leisure-time physical activity × 4. Any missing MET score were regarded as 
0. The MET expresses the energy cost of physical activities as a multiple of the resting metabolic rate.
Statistical analysis. Analysis of variance (ANOVA) and Bonferroni method for multiple comparisons 
were used to determine differences in cross-sectional characteristics between groups, for continuous data with 
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a normal and non-normal distribution, after the log-transformation. The chi-squared test was used for dichoto-
mous and categorical data. Multiple linear regression models were applied to assess multivariable associations 
between body weight and pulmonary function parameters. Physical activity (MET score) was first transformed 
to categorical variable based on quartiles and then used in the regression analysis. Where there was evidence of 
non-linearity in Kernel-weighted local polynomial smoothing, a two-line piecewise linear model with a single 
change point was estimated by including all possible values for the change point and choosing the value with the 
highest likelihood. Then we applied a restricted cubic spline with three knots to explore the non-linear associa-
tion. The first and last knots were placed at percentage 1 and percentage 99 of the examined parameters, and the 
middle one was placed at the point chosen by the two-line piecewise linear model. As obesity’s magnitude and 
distribution are dissimilar according to sex, results are shown for the males and females separately.
A 2-sided p-value < 0.05 was considered for statistical significance. All analyses were weighted to represent 
the U.S. population and to account for the intricate survey design and was performed in Stata version 15.0 
(StataCorp LLC, College Station, TX, USA).
Data availability
The study was approved by the National Center for Health Statistics institutional review board, and written 
informed consent was received from all participants. All methods were carried out in accordance with relevant 
guidelines and regulations.
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